Viewing Study NCT02166658


Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-02-25 @ 4:49 PM
Study NCT ID: NCT02166658
Status: TERMINATED
Last Update Posted: 2018-01-23
First Post: 2014-06-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)
Sponsor: AIO-Studien-gGmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module